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Abstract EDG-3 is a receptor for sphingosine-1-phosphate
mapped on human chromosome 9q22.1^q22.2. We used the
compact Fugu genome for its linkage analysis. The Fugu EDG-3
was composed of one intron and two exons, encoding a 384 amino
acid protein that has 56.9% homology with the human EDG-3.
Approximately 3 kb apart, a neuronal Shc (N-Shc) gene was
identified. It spans 7 kb containing 12 coding exons, and has an
overall 53.4% similarity with the human protein. We mapped the
human N-Shc gene to chromosome 9q21.3^q22.2. This is the first
report of the genomic structure and the linkage of these two
genes conserved between Fugu and human.
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1. Introduction
G protein-coupled receptors (GPCRs) are large superfami-
lies which transduce extracellular signals into intracellular
pathways by coupling to G proteins, and which share a com-
mon structure of seven transmembrane domains [1]. The se-
quences of these domains are well conserved for each isoform,
allowing the isolation of homologues even from distantly re-
lated species. The receptor, endothelial di¡erentiation gene 1
(EDG-1), was discovered as an immediate early gene induced
by the tumor promoter phorbol myristic acetate [2]. Sphingo-
sine-1-phosphate (S1P) [3,4] and lysophosphatidic acid (LPA)
[5] have recently been identi¢ed as ligands for it. We previ-
ously reported the isolation of a related gene, EDG-3, from a
human genomic library and mapped it to human chromosome
9q22.1^q22.2 [6]. We were interested to obtain further infor-
mation on this receptor and to do this, we used the compact
genome of Fugu rubripes in which a number of GPCR families
have been studied [7^9]. In this paper, we report the isolation
of the Fugu EDG-3 receptor and N-Shc genes, which we
found to be closely linked. We show that this linkage is also
conserved in the human genome.
2. Materials and methods
2.1. Isolation and sequencing of cosmid clone
A partial sequence of the Fugu EDG-3 gene was obtained by PCR
with degenerate primers using Fugu genomic DNA as a template.
Speci¢c EDG-3 primers (FEDG-F: TGTAGATGATGGGATT-
CATGGCCG, FEDG-R: TCCTCCCGCTCTACACCAAGAAAT)
were then designed and used for the PCR screening of serial dilutions
of a Fugu cosmid library on the sets of 96 microtiter plates. The
cycling time used was 0.5 min at 95‡C, 0.5 min at 60‡C, 1.0 min at
72‡C, for 35 cycles. Positive cosmids were picked and grown in 3 ml
cultures overnight and the DNA was puri¢ed. For sequence determi-
nation of the full-length gene, selected fragments of the X23 cosmid
were subcloned into a plasmid vector and sequenced by a combination
of random sequence of sonicated DNA fragments (shotgun sequence)
and primer walking methods. The sequence was determined on both
strands. The sequence data were assembled by the Lasergene software
and contigs were searched by BLAST using the SwissProt database.
2.2. Determination of cDNA sequence and exon-intron boundaries
To determine the exact exon-intron boundaries, Fugu liver or brain
RNA was prepared by Trizol reagent from Gibco-BRL, and 3 Wg each
of total RNA was used for the ¢rst strand cDNA synthesis, using the
¢rst strand cDNA synthesis kit from Gibco-BRL. RT-PCR reaction
was carried out to amplify the Fugu EDG-3 fragment using the liver
cDNA, and the N-Shc fragment using brain cDNA. The PCR frag-
ment was subcloned into the plasmid vector and the sequence was
determined on both strands. The cDNA sequence was compared with
the corresponding part of the genomic sequence of each gene and
exon-intron boundaries were determined.
2.3. Long distance PCR of Fugu genes
The speci¢c primers for the Fugu EDG-3 and N-Shc gene were
made at 5P and 3P of each gene (N-Shc_5PF: CGCCTATTAGCAAT-
CACAGGCCACCTGA, N-Shc_3PR: CCAATTCTGTCCGCTGG-
AAGTGAACTGT, EDG-3_5PF: GTTGTAGTGCAGGTAGATCA-
GAGGGTTG, EDG-3_3PR: ACGGAGGGAGATGAGCTGCAGA-
CGGAAA). The long distance PCR was performed using LA Taq
polymerase from Takara, with various combinations of these primers.
The X23 cosmid DNA was used as a template and PCR was carried
out with cycling of 0.5 min at 95‡C, 0.5 min at 62‡C and 4 min at
68‡C for 35 cycles. The PCR sample was run on agarose gel with
molecular weight markers. The sequence of the PCR product was
partially determined to con¢rm that the correct fragment had been
ampli¢ed by PCR.
2.4. Fluorescence in situ hybridization (FISH) of the human N-Shc
gene
Lymphocytes isolated from human blood were cultured in K-mini-
mal essential medium (K-MEM) supplemented with 10% fetal calf
serum and phytohemagglutinin (PHA) at 37‡C for 68^72 h. The lym-
phocyte cultures were treated with bromodeoxyuridine (0.18 mg/ml)
to synchronize the cell population. The synchronized cells were
washed three times with serum-free medium to release the block
and re-cultured at 37‡C for 6 h in K-MEM with thymidine (2.5 Wg/
ml). Cells were harvested and slides were made using standard proce-
dures including hypotonic treatment, followed by ¢xing and air-dry-
ing. The entire coding sequence of the human N-Shc gene was ampli-
¢ed from human cortex cDNA with speci¢c primers, and this cDNA
probe was biotinylated with dATP using the BRL BioNick labeling
kit (15‡C, 1 h). The procedure for FISH detection was preformed as
previously described [20,21]. Brie£y, slides were baked at 55‡C for 1 h.
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After RNase treatment, the slides were denatured in 70% formamide
in 2USSC for 2 min at 70‡C followed by dehydration with ethanol.
Probes were denatured at 75‡C for 5 min in a hybridization mix
consisting of 50% formamide and 10% dextran sulfate. Probes were
loaded on the denatured chromosomal slides. After overnight hybrid-
ization, slides were washed and detected as well as ampli¢ed. FISH
signals and the 4P6P-diamidino-2-phenylindole dihydrochloride
(DAPI) banding pattern were recorded separately by taking photo-
graphs, and the assignment of the FISH mapping data with chromo-
somal bands was achieved by superposing FISH signals with DAPI
banded chromosomes.
3. Results
3.1. Isolation and characterization of Fugu EDG-3 gene
The Fugu EDG-3 gene was obtained by PCR screening of a
cosmid library using Fugu EDG-3 speci¢c primers. The DNA
of one cosmid, X23, was digested with a number of restriction
enzymes and a 3.5 kb ClaI fragment was used to determine
the sequence of the full-length EDG-3 gene. To con¢rm exon-
intron boundaries, a Fugu EDG-3 cDNA was isolated from a
Fugu liver cDNA library by PCR and the PCR fragment was
directly sequenced. Comparison of the cDNA and genomic
sequences showed that Fugu EDG-3 gene is composed of
two exons (Fig. 1B). The ¢rst small exon is untranslated,
and the second exon contains a 43 bp 5P UTR, 1.2 kb ORF
and 3P UTR. The intron between two exons is 0.3 kb in
length. The alignment of the deduced amino acid sequences
of EDG-3 (Fugu and human) and EDG-1 (human and mouse)
is presented in Fig. 2. The Fugu gene encodes a 384 amino
acid protein similar in size to the human EDG-3 protein (378
amino acids). At the amino acid level, the Fugu EDG-3
showed 56.9% homology with human EDG-3 and 43.8%
with human EDG-1. The homology between Fugu and human
EDG-3 increased to 73.9% in the transmembrane regions. A
protein motif search indicated potential N-glycosylation sites
and phosphorylation sites in the Fugu EDG-3 gene, some of
them are shared with the human gene (Fig. 2).
3.2. Isolation and analysis of Fugu N-Shc gene
The cosmid was scanned by shotgun sequencing to ¢nd
other genes. Sonicated 400^800 bp fragments were subcloned
into a plasmid vector and sequenced. The sequences were
searched against the SwissProt database, and revealed the
presence of the N-Shc gene. The full-length sequence of this
gene was determined, and a cDNA was isolated from a Fugu
brain cDNA library by PCR and the fragment was sequenced.
The genomic and cDNA sequences were compared to deter-
mine exon-intron boundaries (Fig. 1A). The Fugu introns
range from 67 to 1810 bp in size, with the largest intron after
exon 1. The genomic organization of the Fugu N-Shc gene is
presented in Fig. 1B. The Fugu N-Shc gene spans 7 kb of
genomic DNA and is composed of 12 coding exons with
2130 bp of ORF that covers the initiation methionine to the
stop codon. Two in-frame initiation codons, corresponding to
those of the human N-Shc gene, were found (Fig. 1B). The
ORF beginning with these start codons encodes 660 and 505
amino acid proteins, and the predicted molecular weight of
these proteins is 70.6 and 55.3 kDa, respectively. The align-
ment of the Fugu amino acid sequence with the human N-Shc
and Shc genes is shown in Fig. 3. Together with the positions
of the introns, the phosphotyrosine binding (PTB) and the Src
homology 2 (SH2) domains are conserved in the Fugu gene,
and the sequence similarity of these domains between Fugu
and human is 80.6% and 77.7%, respectively. In addition, the
consensus Grb2 SH2 site (‘YVNT’ or ‘YVNV’) is well con-
served, but the surrounding region, called the collagen homol-
ogy (CH), was only 42.7% similar. The overall homology
between Fugu and human N-Shc protein is 53.4%, and be-
tween Fugu N-Shc and human Shc is 43.7%.
3.3. The physical distance of Fugu EDG-3 and N-Shc genes
The physical distance between the Fugu EDG-3 and N-Shc
genes was determined by long distance PCR. Using speci¢c
primers for the Fugu EDG-3 and N-Shc genes, the two genes
Fig. 1. A: Intron sizes and the donor and acceptor splice sites of the Fugu N-shc gene. B: Genomic organization of the Fugu N-Shc and
EDG-3 genes. The sequences of the two genes were obtained by a cosmid clone isolated from a Fugu genomic library. The exon-intron bounda-
ries were determined by comparing genomic and cDNA sequences of each gene. The exon numbers of both genes are shown. The arrows show
the positions of the potential initiation codons in the N-Shc gene. The white box indicates untranslated regions and the black box indicates the
coding regions.
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are approximately 3 kb apart in a tail to tail orientation (Fig.
4). The partial sequence of this fragment was determined to
con¢rm that the intergenic region had been correctly ampli-
¢ed.
3.4. The chromosome mapping of the human N-Shc gene
Since the N-Shc gene has not yet been mapped in any
species, human N-Shc cDNA was prepared by PCR from a
human cerebral cortex cDNA library. The fragment was la-
beled and used for FISH mapping of the human N-Shc gene.
Under the conditions used, hybridization e⁄ciency was ap-
proximately 68% for this probe (68 out of 100 checked mitotic
¢gures showed signals on one pair of the chromosomes). Since
DAPI banding was used to identify the speci¢c chromosome,
the signal from the probe could be assigned to the long arm of
chromosome 9, and a detailed analysis based on 10 mitoses
showed that the human N-Shc gene maps to the chromosome
9q21.3^q22.2 region (Fig. 5A).
4. Discussion
The EDG receptors were originally classi¢ed as orphan
receptors. EDG-1 was cloned from endothelial cells [2] in-
duced by addition of PMA, which stops endothelial cell
growth and induces its di¡erentiation into a capillary-like tu-
bule structure [10]. Recently S1P, a platelet-derived lipid me-
diator that was known to evoke adenylate cyclase inhibition,
mitogen-activated protein (MAP) kinase activation and mito-
genesis, was shown to bind to EDG-1 with high a⁄nity [3,4].
In addition, LPA, a platelet-derived bioactive lipid structur-
ally related to S1P, was reported to be a low a⁄nity agonist of
EDG-1 [5]. LPA binding to EDG-1 induces receptor phos-
phorylation, MAP kinase activation, as well as Rho-depend-
ent morphogenesis and P-cadherin expression. It is thought
that activation of the endothelial receptor EDG-1 by platelet-
derived lipids LPA and SPP may be important for thrombosis
and angiogenesis [5]. The human EDG-3 has been shown to
activate serum response element-driven transcriptional report-
er gene in response to S1P, dihydro-S1P and sphingosylphos-
phorylcholine, but not to LPA. This result indicated that
EDG-3 is a functional receptor for S1P and perhaps other
lysosphingolipids [11].
We cloned the EDG-3 gene from the Fugu genome, and
found that it has two exons split by an intron. This exon-
Fig. 2. Alignment of the deduced amino acid sequences of Fugu and human EDG-3 and EDG-1 genes. The sequence alignment was carried
out using Clustal V software. The seven transmembrane domains are indicated by lines and Roman numerals. The conserved amino acid resi-
dues are shown in shaded boxes. The potential N-glycosylation sites (*) and phosphorylation sites (b) are marked. Amino acid numbers are in-
dicated at the right of each row.
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intron structure is similar to that of the reported mouse EDG-
1 gene, with a short 5P untranslated exon, and a second exon
containing a 1.2 kb ORF and 43 bp 5P UTR (Fig. 1B). This
gene structure, a small untranslated ¢rst exon, followed by a
second exon encoding the whole protein sequence, is seen in
other GPCRs such as cannabinoid type 1 and muscarinic
receptors. In the case of the Fugu EDG-3 gene, the intron
size is 0.3 kb which is smaller than that of the mouse EDG-
1 gene (1.6 kb) (Fig. 1B). In the mouse EDG-1 gene, it was
reported that the intron has a repressor site for gene expres-
sion [12]. Although the intron in the Fugu EDG-3 gene is
smaller, the similarity of sequence and genomic structure of
the human and Fugu genes suggests that the Fugu intron may
have a similar function as seen in the mouse EDG-1 gene.
The Fugu N-Shc gene was located 3 kb away from the
EDG-3 gene (Fig. 1B). The Fugu N-Shc gene consists of 12
coding exons, and the introns range in size from 67 to 1810 bp
with the largest intron positioned between exon 1 and 2 (Fig.
1A). The genomic structure of N-Shc gene has not been de-
termined in any species, and the human [13] and rat [14] genes
have been sequenced only at the cDNA level. As the human
Shc gene has high homology with the N-Shc gene and shares
similar functional domains, its genomic structure was com-
pared with that of the Fugu N-Shc gene. The human Shc
Fig. 3. Alignment of the deduced amino acid sequences of Fugu and human N-Shc and human Shc genes. The 70.6 kDa of Fugu N-shc, 64
kDa of human N-Shc and 62 kDa of human Shc protein were aligned. The conserved amino acid residues are shown in shaded boxes. The po-
sitions of Fugu N-Shc introns are marked (S). The PTB, Grb2 binding and SH2 domains are shown with overlines. The alternative start me-
thionine of the N-Shc gene is indicated (*1 or *2). Amino acid numbers are indicated at the right of each row.
FEBS 22651 22-9-99
F. Yamaguchi et al./FEBS Letters 459 (1999) 105^110108
gene consists of 13 exons [15], whereas the Fugu N-Shc gene is
composed of 12 exons. This di¡erence is due to the existence
of a 5P untranslated exon in the Shc gene. At the protein level,
two isoforms of human N-Shc protein (64 and 52 kDa) were
detected by Western blot analysis [13,14]. As the human N-
Shc gene has two potential initiation methionines, the mech-
anism of choosing one of these initiation sites controls the
generation of two di¡erent alternative splicing variants of
the N-Shc gene. 5P RT-PCR of Fugu cDNA also suggested
the existence of these two isoforms. The calculated molecular
weight of these isoforms is 70.6 and 55.3 kDa, respectively,
quite similar to those of the human N-Shc isoforms. On the
other hand, the Shc gene contains three potential initiation
methionines, and three splicing variants (66, 52 and 46 kDa)
have been detected by Western blot analysis [15]. These splic-
ing variants are generated with or without using the ¢rst un-
translated exon by a distinct mechanism.
The similarity in sequence and genomic organization of the
N-Shc and Shc genes suggests that these genes derive from a
common ancestor. Both are adapter proteins, and are in-
volved in phosphotyrosine signalling following extracellular
stimulation through GPCR and growth factor receptors.
For example, Shc was phosphorylated by EGFR following
GPCR stimulation by thrombin, endothelin-1 or LPA [16].
Both Shc and N-Shc can bind to activated TrkB receptor
following stimulation with brain-derived neurotrophic factor
[13]. However, the distribution of Shc and N-Shc proteins is
di¡erent; the former is expressed everywhere except in brain
[17], whereas N-Shc is abundantly expressed in the central
nervous system (CNS) and is an important adapter molecule
in the CNS.
The PTB, CH and SH2 domains are found in both Shc and
N-Shc genes and mediate protein interactions. The homology
of the PTB and SH2 domains between Fugu and human N-shc
is very high, suggesting that the Fugu gene may act as an
adapter protein in a similar manner. However, the homology
of the CH region is lower (42.7%), and was low between
human Shc and N-Shc protein (34.3%). This domain is known
to be responsible for the association with SH3-containing pro-
teins [10,18,19]. In the CH domain, the consensus sequence
‘YVNT’ was found in both the Fugu and human genes and
Fig. 4. Long distance PCR of Fugu EDG-3 and N-Shc genes. Two
primer sets, N-Shc_5PF and N-Shc_3PR, and EDG-3_5PF and EDG-
3_3PR, were used for the PCR with four di¡erent combinations,
and the PCR products were separated on a 0.7% agarose gel. Mk:
1 kb DNA marker; lane 1: N-Shc_5PF+EDG-3_5PF; lane 2: N-
Shc_5PF+EDG-3_3PR; lane 3: N-Shc_3PR+EDG-3_5PF; lane 4: N-
Shc_3PR+EDG-3_3PR.
Fig. 5. FISH mapping of the human N-Shc gene. A: Diagram of
FISH mapping results for probe N-Shc. Each dot represents the
double FISH signals detected on human chromosome 9. B: Exam-
ple of FISH mapping. The left panel shows the FISH signals on
chromosome; the right panel shows the same mitotic ¢gure stained
with DAPI to identify chromosome 9.
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matches the motif recognized by the Grb2 SH2 domain. The
tyrosine 474 residue in the ‘YVNT’ motif of human N-Shc
protein is a putative tyrosine-phosphorylation site and is con-
sidered to be important for the signalling [13]. The Fugu gene
contains the corresponding tyrosine residue at position 424,
which might be essential for N-Shc signalling. However, the
divergence of the CH domain between Fugu and human N-shc
protein may re£ect di¡erent functions in the two species.
Acknowledgements: This research was ¢nancially supported by the
Louis Jeantet Foundation, and by a Grant-in-Aid for Scienti¢c Re-
search (A) of the Ministry of Education, Science and Culture, Japan.
References
[1] Probst, W.C., Snyder, L.A., Schuster, D.I., Brosius, J. and Seal-
fon, S.C. (1992) DNA Cell Biol. 11, 1^20.
[2] Hla, T. and Maciag, T. (1990) J. Biol. Chem. 265, 9308^9313.
[3] Lee, M.J., Van Brocklyn, J.R., Thangada, S., Liu, C.H., Hand,
A.R., Menzeleev, R., Spiegel, S. and Hla, T. (1998) Science 279,
1552^1555.
[4] Zondag, G.C., Postma, F.R., Etten, I.V., Verlaan, I. and Moo-
lenaar, W.H. (1998) Biochem. J. 330, 605^609.
[5] Lee, M.J., Thangada, S., Liu, C.H., Thompson, B. and Hla, T.
(1998) J. Biol. Chem. 21, 22105^22112.
[6] Yamaguchi, F., Tokuda, M., Hatase, O. and Brenner, S. (1996)
Biochem. Biophys. Res. Commun. 227, 608^614.
[7] Yamaguchi, F. and Brenner, S. (1997) Gene 191, 219^223.
[8] Yamaguchi, F., Macrae, A.D. and Brenner, S. (1996) Genomics
35, 603^605.
[9] Macrae, A.D. and Brenner, S. (1995) Genomics 25, 436^446.
[10] Montesano, R. and Orci, L. Phorbol esters induce angiogenesis
in vitro from large-vessel endothelial cells, (1987) J. Cell. Physiol.
130, 284^291.
[11] An, S., Bleu, T., Huang, W., Hallmark, O.G., Coughlin, S.R. and
Goetzl, E.J. (1997) FEBS Lett. 417, 279^282.
[12] Liu, C.H. and Hla, T. (1997) Genomics 43, 15^24.
[13] Nakamura, T., Sanokawa, R., Sasaki, Y., Ayusawa, D., Oishi,
M. and Mori, N. (1996) Oncogene 13, 1111^1121.
[14] Nakamura, T., Muraoka, S., Sanokawa, R. and Mori, N. (1998)
J. Biol. Chem. 273, 6960^6967.
[15] Migliaccio, E., Mele, S., Salcini, A.E., Pelicci, G., Lai, K.M.,
Superti Furga, G., Pawson, T., Di Fiore, P.P., Lanfrancone, L.
and Pelicci, P.G. (1997) EMBO J. 16, 706^716.
[16] Daub, H., Weiss, F.U., Wallasch, C. and Ullrich, A. (1996) Na-
ture 379, 557^560.
[17] Pelicci, G., Lanfrancone, L., Grignani, F., McGlade, J., Cavallo,
F., Forni, G., Nicoletti, I., Pawson, T. and Pelicci, P.G. (1992)
Cell 70, 93^104.
[18] Harrison Findik, D., Susa, M. and Varticovski, L. (1995) Onco-
gene 10, 1385^1391.
[19] Pelicci, G., Lanfrancone, L., Salcini, A.E., Romano, A., Mele, S.,
Grazia Borrello, M., Segatto, O., Di Fiore, P.P. and Pelicci, P.G.
(1995) Oncogene 11, 899^907.
[20] Heng, H., Squire, J. and Tsui, L.-C. (1992) Proc. Natl. Acad. Sci.
USA 89, 9509^9513.
[21] Heng, H. and Tsui, L.-C. (1993) Chromosoma 102, 325^332.
FEBS 22651 22-9-99
F. Yamaguchi et al./FEBS Letters 459 (1999) 105^110110
